TRIM22 and glioblastoma: For example Jianxiong Ji et al. showed that knockout of TRIM22 using CRISPR-Cas9 decreased the proliferation of glioblastoma cells in vitro and in situ xenotransplantation models of glioblastoma, while overexpression of TRIM22 exerted the opposite effects (Ji et al., 2021).